- Home
- XYL vs CAH Comparison
XYL vs CAH Comparison
Compare XYL & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYL
- CAH
- Stock Information
- Founded
- XYL 2011
- CAH 1979
- Country
- XYL United States
- CAH United States
- Employees
- XYL N/A
- CAH N/A
- Industry
- XYL Fluid Controls
- CAH Other Pharmaceuticals
- Sector
- XYL Industrials
- CAH Health Care
- Exchange
- XYL Nasdaq
- CAH Nasdaq
- Market Cap
- XYL 28.8B
- CAH 31.2B
- IPO Year
- XYL N/A
- CAH N/A
- Fundamental
- Price
- XYL $119.88
- CAH $137.18
- Analyst Decision
- XYL Buy
- CAH Buy
- Analyst Count
- XYL 10
- CAH 15
- Target Price
- XYL $149.89
- CAH $137.27
- AVG Volume (30 Days)
- XYL 1.6M
- CAH 2.4M
- Earning Date
- XYL 04-29-2025
- CAH 05-01-2025
- Dividend Yield
- XYL 1.33%
- CAH 1.47%
- EPS Growth
- XYL 30.82
- CAH 92.22
- EPS
- XYL 3.65
- CAH 5.36
- Revenue
- XYL $8,562,000,000.00
- CAH $222,276,000,000.00
- Revenue This Year
- XYL $2.98
- CAH N/A
- Revenue Next Year
- XYL $5.29
- CAH $8.67
- P/E Ratio
- XYL $32.84
- CAH $25.68
- Revenue Growth
- XYL 16.27
- CAH 2.91
- 52 Week Low
- XYL $113.26
- CAH $93.17
- 52 Week High
- XYL $146.08
- CAH $138.62
- Technical
- Relative Strength Index (RSI)
- XYL 40.48
- CAH 70.48
- Support Level
- XYL $116.52
- CAH $125.14
- Resistance Level
- XYL $123.85
- CAH $138.62
- Average True Range (ATR)
- XYL 2.34
- CAH 2.20
- MACD
- XYL -0.23
- CAH 0.71
- Stochastic Oscillator
- XYL 42.03
- CAH 89.32
About XYL Xylem Inc. New
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.